Summary

Eligibility
for people ages 12-18 (full criteria)
Location
at UCSF
Dates
study started
completion around

Description

Summary

The goal of this clinical trial is to learn if shared medical appointment is an acceptable way to deliver care to youth with type 2 diabetes.

The main question[s] it aims to answer are:

  • Is shared medical appointments an acceptable care delivery model for this population?
  • Does shared medical appointment improve psychosocial outcomes for this population?

Participants will attend quarterly clinic appointments and group activities and take surveys. Researchers will compare this intervention to standard of care.

Official Title

Implementation of Team Clinic for Type 2 Diabetes (TCT2): A Randomized Standard Care-controlled Two-site 80-subject Clinical Trial of Shared Medical Appointment Model for Adolescents With Type 2 Diabetes

Keywords

Type 2 Diabetes, Diabetes Mellitus, Type 2 Diabetes Mellitus, Shared Medical Appointments

Eligibility

For people ages 12-18

Patient/AYA Participants

Inclusion Criteria:

  • Receives care for type 2 diabetes at either CHLA or UCSF
  • English speaking youth
  • Youth prescribed medication for type 2 diabetes
  • English or Spanish speaking caregivers
  • Age 12 to 18 years old at the time of enrollment
  • Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys

Exclusion Criteria:

  • Participants who are non-verbal or unable to participate in group activities and discussions
  • Pregnancy
  • Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent

Caregiver/Parents Participants

Inclusion Criteria:

  • Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant.
  • Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session
  • Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys.

Exclusion Criteria:

-Inability or unwillingness of individual to give written informed consent

Locations

  • University of California, San Francisco
    San Francisco California 94143-0434 United States
  • Children's Hospital Los Angeles
    Los Angeles California 91316 United States

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Children's Hospital Los Angeles
ID
NCT06923046
Study Type
Interventional
Participants
Expecting 160 study participants
Last Updated